SCHEMBL5998196

SCHEMBL5998196

COC(=O)C(CN1C(=O)C=C(c2ccccc2)C1=O)C1(C)OCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42
ACHE P22303 2/20 0.38
RGS4 P49798 1/20 0.38
FOS P01100 1/20 0.34
JUN P05412 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
AVPR1A P37288 1/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 3/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 2/20 0.34
CCR6 P51684 2/20 0.34
HPGD P15428 1/20 0.34
ALOX12 P18054 1/20 0.34
CACNA1B Q00975 1/20 0.34
APBA1 Q02410 1/20 0.34
ITGB1 P05556 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5998659 0.91 RGS4 (0.40) DRD2DRD3RGS4FOSJUN
SCHEMBL5998352 0.90 DRD2 (0.43) DRD2DRD3ACHERGS4FOS
SCHEMBL5998394 0.84 ACHE (0.40) ACHEAVPR1AALDH1A1ITGB1ITGA4
SCHEMBL5996133 0.81 DRD2 (0.40) DRD2DRD3ACHERGS4FOS
SCHEMBL5998145 0.79 RGS4 (0.44) DRD2DRD3ACHERGS4FOS
SCHEMBL5997311 0.77 MMP1 (0.38) DRD2DRD3AVPR1AMAPTALDH1A1
SCHEMBL5997885 0.76 ACHE (0.39) ACHEAVPR1AALDH1A1
SCHEMBL5998838 0.75 ALDH1A1 (0.38) AVPR1AMAPTALDH1A1GAAHPGD
SCHEMBL5998825 0.75 MEN1 (0.39) ACHEAVPR1AMAPTALDH1A1HPGD
SCHEMBL5998111 0.74 TNF (0.35) ACHEAVPR1AMAPTNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7094908-B2 Reduction of carbonyl compounds using the carbonyl reductase of Kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-08-22 US disclosed
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus CBR1, CBR3, DCXR DRD2 3742/4885DRD3 3191/4885ACHE 3777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.